Web Results

Prognostic Model Predicting Metastatic Castration-Resistant ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC3833929/

Oct 17, 2013 ... Susan Halabi, <sup>corresponding author</sup> .... safety of satraplatin plus prednisone vs placebo plus prednisone in men with mCRPC who were .... Armstrong et al. developed and validated a prognostic model of OS in men who failed ...

Circulating tumor cells in patients with metastatic castration resistant ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4199652/

Sep 27, 2014 ... Reanalyzing data from a previously randomized trial, Halabi et al have ... failure ( ∼8 months before docetaxel vs ∼3 months post-docetaxel).

Circulating Tumor Cells in Prostate Cancer Diagnosis and ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC4149177/

He et al. [33] were able to isolate CTCs this way and observed that 10 of 13 PC patients had a ..... The v-ets erythroblastosis virus E26 oncogene homolog, ERG, is a ..... Murray NP, Reyes E, Badinez L, Orellana N, Fuentealba C, Olivares R, et al. ... Armstrong AJ, Shen T, Halabi S, Kemeny G, Bitting RL, Kartcheske P, et al.

Pathogenicity of severe acute respiratory coronavirus deletion ...

www.sciencedirect.com/science/article/pii/S004268220800175X

Expression of E gene was abolished as previously described (DeDiego et al., 2007). ..... The cDNAs were amplified by PCR using sense primers SARS-25211- VS ..... H.P. Jia, C. Halabi, C.D. Sigmund, D.K. Meyerholz, P. Kirby, D.C. Look, S. Perlman ... Pewe et al., 2005; L. Pewe, H. Zhou, J. Netland, C. Tangudu, H. Olivares, ...

Frontiers | Fronto-Striatal Atrophy in Behavioral Variant ...

journal.frontiersin.org/article/10.3389/fneur.2015.00147/full

Jul 1, 2015 ... Hamalainen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, Huuskonen J, et al. ... Halabi C, Halabi A, Dean DL, Wang PN, Boxer AL, Trojanowski JQ, et al. ... in Parkinson's disease versus behavioural variant frontotemporal .... Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, Hose DR, et al.

Therapy of metastatic bladder carcinoma

annonc.oxfordjournals.org/content/18/suppl_6/vi153.full.pdf

vasculature (inhibition of angiogenesis) by inhibiting V-RAF murine sarcoma viral oncogene ... Boutan-Laroze A, Mahjoubi M, Droz JP et al. .... Olivares J, Hyman W, Senzer N et al. A phase II trial ... Phillips G, Sanford D, Halabi S et al. Phase II  ...

Prostate Cancer DREAM Challenge 2015 - Team Marie - syn4485029

www.synapse.org/#!Synapse:syn4485029

I started by building a model based using the initial selection of variables used by Halabi et al. in their work, plus a number of obviously related or potentially ...

More Info

A prognostic index model for predicting overall survival in patients ...

www.ncbi.nlm.nih.gov

Dec 18, 2015 ... [28] and Halabi et al. .... Beer TM, Armstrong AJ, Rathkopf DE et al. ... Abiraterone acetate plus prednisone versus placebo plus prednisone in ...

The site of visceral metastases (mets) to predict overall survival (OS ...

meetinglibrary.asco.org

Susan Halabi, William Kevin Kelly, Haojin Zhou, Andrew J. Armstrong, David ... ( CI) for comparing pts with lung mets vs. non-visceral mets and liver mets vs. lung  ...

Systemic Chemotherapy for Advanced Bladder Cancer: Update and ...

jco.ascopubs.org

Dec 10, 2006 ... Studies conducted by Sternberg et al demonstrated that the M-VAC regimen ... arm (10 v 4.3, and 12.5 v 8.2 months, respectively; Fig 1) Logothetis et al also ..... Olivares J, Hyman W, Senzer N, et al: A Phase II trial of gemcitabine and ... Phillips G, Sanford D, Halabi S, et al: Phase II study of cisplatin (C), ....